Fund HoldingsBain Capital Life Sciences Investors, LLC

Total Portfolio Value
$850.10M
Total Bought
$182.90M
Total Sold
$238.24M
Net Transaction
-$55.34M
Filing Period:
Securities
SharesValue ($K)
Q3 2024
Q4 2024
Change
Q3 2024
Q4 2024
Weight (%)
Change
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
10,473,91310,719,110+245,197173,867275,48132.41%+101,614
OLEMA PHARMACEUTICALS INC(OLMA)07,470,214+7,470,214043,5515.12%+43,551
UPSTREAM BIO INC02,295,322+2,295,322037,7354.44%+37,735
CIDARA THERAPEUTICS INC703,080703,08007,55818,8992.22%+11,341
PHARVARIS N V
COM
3,303,3813,303,381061,17963,3267.45%+2,147
X4 PHARMACEUTICALS INC16,915,78416,915,784011,32212,4091.46%+1,088
XILIO THERAPEUTICS INC4,566,8174,566,81703,5974,3610.51%+764
NEWAMSTERDAM PHARMA COMPANY
*W EXP 99/99/999
100,000100,00007001,4250.17%+725
RAPID MICRO BIOSYSTEMS INC8,434,5608,434,56007,5077,5910.89%+84
ATEA PHARMACEUTICALS INC2,485,6382,485,63808,3278,3270.98%0
INVIVYD INC1,799,5951,799,59501,8367970.09%-1,038
C4 THERAPEUTICS INC1,111,9101,111,91006,3384,0030.47%-2,335
NAUTILUS BIOTECHNOLOGY INC2,000,0001,759,000-241,0005,7002,9550.35%-2,745
MARINUS PHARMACEUTICALS INC2,693,3802,693,38004,7401,4410.17%-3,299
CENTURY THERAPEUTICS INC5,410,3615,410,36109,2525,4640.64%-3,787
KYVERNA THERAPEUTICS INC3,368,3703,368,370016,47112,5981.48%-3,874
MERSANA THERAPEUTICS INC8,663,6738,663,673016,37412,3891.46%-3,985
SYROS PHARMACEUTICALS INC2,750,1512,750,15105,9136320.07%-5,281
CABALETTA BIO INC2,760,8882,760,888013,0316,2670.74%-6,764
SOLID BIOSCIENCES INC4,034,5824,034,582028,12116,1381.90%-11,983
TANGO THERAPEUTICS INC(TNGX)2,712,0082,712,008020,8828,3800.99%-12,502
SAVARA INC(SVRA)14,565,45714,565,457061,75844,7165.26%-17,042
ANNEXON INC(ANNX)8,449,7485,249,069-3,200,67950,02326,9283.17%-23,095
DIANTHUS THERAPEUTICS INC(DNTH)3,013,4232,689,707-323,71682,50858,6366.90%-23,872
DISC MEDICINE INC(IRON)1,795,735983,500-812,23588,24262,3547.33%-25,889
NUVALENT INC2,697,2671,447,267-1,250,000275,930113,29213.33%-162,638
Page 1 of 1